These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11026037)

  • 1. [Recent prognostic factors of breast cancers].
    Sato F; Umemura S; Osamura Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():478-80. PubMed ID: 11026037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cell cycle regulators as prognostic factors of breast cancers].
    Ohta T; Fukuda M
    Nihon Rinsho; 2000 Apr; 58 Suppl():448-53. PubMed ID: 11026032
    [No Abstract]   [Full Text] [Related]  

  • 3. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
    Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
    Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways in early onset sporadic breast cancer of patients in Indonesia.
    Sutandyo N; Suzanna E; Haryono SJ; Reksodiputro AH
    Acta Med Indones; 2008 Jul; 40(3):139-45. PubMed ID: 18838752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
    Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
    Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
    Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
    Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cyclin D1 discriminate between BRCA2 and BRCAX breast cancers?
    Yan M; ; Fox SB
    Histopathology; 2009 Nov; 55(5):625-6. PubMed ID: 19780858
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer: the search for new prognostic markers.
    Davis AR
    Br J Biomed Sci; 1996 Jun; 53(2):157-61. PubMed ID: 8757694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.
    Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A
    Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
    Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of telomerase in cancer.
    Hiyama E; Hiyama K
    Oncogene; 2002 Jan; 21(4):643-9. PubMed ID: 11850791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
    Wagner U; Süess K; Luginbühl T; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Jordan P; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    J Pathol; 1999 May; 188(1):44-50. PubMed ID: 10398139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
    Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
    Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of breast cancer in young women: prognosis and prognostic factors.
    Saito E
    Nihon Geka Hokan; 1996 Nov; 65(4):133-44. PubMed ID: 9528272
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma.
    Wang SL; Chen WT; Li SH; Li SW; Yang SF; Chai CY
    APMIS; 2007 Jan; 115(1):17-21. PubMed ID: 17223847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
    Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
    Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
    Ikeda S; Shibata T; Funakoshi N
    Rinsho Byori; 2005 Jun; 53(6):487-93. PubMed ID: 16026073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic markers and long-term prognosis in breast cancer.
    Burtness BA
    Cancer J Sci Am; 1997; 3(4):211-2. PubMed ID: 9263626
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
    Penault-Llorca F; Abrial C; Raoelfils I; Chollet P; Cayre A; Mouret-Reynier MA; Thivat E; Mishellany F; Gimbergues P; Durando X
    Oncologist; 2008 Dec; 13(12):1235-45. PubMed ID: 19091781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Poremba et al Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 2002; 198: 181-189.
    Mokbel K; Newbold RF
    J Pathol; 2003 Apr; 199(4):542. PubMed ID: 12635146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.